Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Proguanil 25mg / Atovaquone 62.5mg tablets
0504010U0AAABAB
|
Proguanil hydrochloride/atovaquone | Proguanil hydrochloride with atovaquone | Infections | 29 |
|
Fusidic acid 250mg/5ml oral suspension
0501070M0AAAAAA
|
Fusidic acid (Systemic) | Fusidic acid | Infections | 26 |
|
Meropenem 500mg powder for solution for injection vials
0501022A0AAAAAA
|
Meropenem | Meropenem | Infections | 26 |
|
Zeffix 100mg tablets
0503010Q0BCABAD
|
Zeffix | Lamivudine | Infections | 26 |
|
Entecavir 1mg tablets
0503031B0AAABAB
|
Entecavir | Entecavir | Infections | 25 |
|
Vancocin Matrigel 125mg capsules
0501070U0BBAAAA
|
Vancocin | Vancomycin hydrochloride | Infections | 25 |
|
Avloclor 250mg tablets
0504010F0BBABAB
|
Avloclor | Chloroquine phosphate | Infections | 24 |
|
Distaclor 500mg capsules
0501021A0BBADAE
|
Distaclor | Cefaclor | Infections | 24 |
|
Flagyl 400mg tablets
0501110C0BCABAJ
|
Flagyl | Metronidazole | Infections | 23 |
|
Lamivudine 50mg/5ml oral solution
0503010Q0AAABAB
|
Lamivudine | Lamivudine | Infections | 23 |
|
Baraclude 0.5mg tablets
0503031B0BBAAAA
|
Baraclude | Entecavir | Infections | 22 |
|
Meropenem 1g powder for solution for injection vials
0501022A0AAABAB
|
Meropenem | Meropenem | Infections | 22 |
|
Rifater tablets
0501090S0BDAAAC
|
Rifater | Rifampicin combined preparations | Infections | 22 |
|
Voriconazole 100mg tablets
0502010D0AAAHAH
|
Voriconazole | Voriconazole | Infections | 22 |
|
Fidaxomicin 40mg/ml oral suspension sugar free
0501070ACAAABAB
|
Fidaxomicin | Fidaxomicin | Infections | 21 |
|
Linezolid 100mg/5ml oral suspension
0501070W0AAABAB
|
Linezolid | Linezolid | Infections | 21 |
|
Sporanox 50mg/5ml oral solution
0502010C0BBACAB
|
Sporanox | Itraconazole | Infections | 21 |
|
Erythroped SF 250mg/5ml oral suspension
0501050H0BDAMAM
|
Erythroped | Erythromycin ethylsuccinate | Infections | 20 |
|
Voractiv tablets
0501090S0BEAAA0
|
Voractiv | Rifampicin combined preparations | Infections | 20 |
|
Ciproxin 500mg tablets
0501120L0BBABAF
|
Ciproxin | Ciprofloxacin | Infections | 19 |
|
Zinnat 250mg tablets
0501021K0BBABAB
|
Zinnat | Cefuroxime axetil | Infections | 19 |
|
Zovirax 800mg dispersible tablets
0503021C0BBAEAE
|
Zovirax (Systemic) | Aciclovir | Infections | 19 |
|
Amoxicillin 1g dispersible tablets sugar free
0501013B0AAAUAU
|
Amoxicillin | Amoxicillin | Infections | 18 |
|
Tamiflu 6mg/ml oral suspension
0503040B0BBAEAG
|
Tamiflu | Oseltamivir phosphate | Infections | 18 |
|
Zovirax Double Strength 400mg/5ml oral suspension
0503021C0BBAFAF
|
Zovirax (Systemic) | Aciclovir | Infections | 18 |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.